跳至主要内容
临床试验/NCT01876316
NCT01876316已完成不适用

A Randomized, Double-blind, Placebo-controlled, Two-way Crossover Trial to Compare Moxifloxacin Induced QT Interval Prolongation in Japanese and Korean Healthy Subjects

Inje University0 个研究点目标入组 40 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
主要终点
double delta QTcF

研究概览

简要总结

The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects

详细描述

The purpose of this study is to explore the ethnic and gender difference in the Moxifloxacin induced QT interval prolongation between Japanese and Korean subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects in Japan and Korea deemed healthy as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, or clinical laboratory determinations.
  • Body Mass Index (BMI) of 17.6 to 26.4 kg/m2, BMI = weight (kg)/ [height (m)]2.

排除标准

  • Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG or clinical laboratory determinations beyond what is consistent with the target population.
  • Any of the following on 12-lead ECG prior to study drug administration, confirmed by repeat.
  • Heart rate ≤ 45 bpmmsec or Heart rate ≥ 100 bpmmsec
  • PR ≥ 210 msec
  • QRS ≥ 120 msec
  • QT ≥ 500 msec
  • QTcF: male ≥ 450 msec, female ≥470msec
  • Iincomplete right bundle branch block
  • Marked Sinus Arrhythmia
  • Wondering pacemaker
  • Atrial rhythm

研究组 & 干预措施

Moxifloxacin

Active Comparator

single oral administration of 400mg of moxifloxacin

干预措施: Moxifloxacin (Drug)

Placebo

Placebo Comparator

single oral administration of 400mg of placebo

干预措施: Placebo (Drug)

结局指标

主要结局

double delta QTcF

时间窗: up to 24 hours

12 point of ECG measurements according to the interventions

次要结局

  • double delta QTcI, double delta QTcSS(up to 24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jae-Gook Shin

Department of Pharmacology and Pharmacogenomics Research Center

Inje University

相似试验